- Home
- GRRR vs LENZ Comparison
GRRR vs LENZ Comparison
Compare GRRR & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRRR
- LENZ
- Stock Information
- Founded
- GRRR 2001
- LENZ 2019
- Country
- GRRR United Kingdom
- LENZ United States
- Employees
- GRRR 142
- LENZ N/A
- Industry
- GRRR Computer Software: Prepackaged Software
- LENZ Medicinal Chemicals and Botanical Products
- Sector
- GRRR Technology
- LENZ Health Care
- Exchange
- GRRR Nasdaq
- LENZ Nasdaq
- Market Cap
- GRRR 478.4M
- LENZ 679.4M
- IPO Year
- GRRR N/A
- LENZ 2021
- Fundamental
- Price
- GRRR $25.91
- LENZ $24.75
- Analyst Decision
- GRRR Buy
- LENZ Strong Buy
- Analyst Count
- GRRR 1
- LENZ 6
- Target Price
- GRRR $18.00
- LENZ $35.40
- AVG Volume (30 Days)
- GRRR 5.5M
- LENZ 150.7K
- Earning Date
- GRRR 04-03-2025
- LENZ 03-19-2025
- Dividend Yield
- GRRR N/A
- LENZ 58.15%
- EPS Growth
- GRRR N/A
- LENZ N/A
- EPS
- GRRR 2.28
- LENZ N/A
- Revenue
- GRRR $78,940,347.00
- LENZ N/A
- Revenue This Year
- GRRR $12.29
- LENZ N/A
- Revenue Next Year
- GRRR $38.43
- LENZ N/A
- P/E Ratio
- GRRR $11.36
- LENZ N/A
- Revenue Growth
- GRRR 424.97
- LENZ N/A
- 52 Week Low
- GRRR $2.09
- LENZ $2.57
- 52 Week High
- GRRR $44.15
- LENZ $38.93
- Technical
- Relative Strength Index (RSI)
- GRRR 49.78
- LENZ 55.66
- Support Level
- GRRR $23.56
- LENZ $21.98
- Resistance Level
- GRRR $44.15
- LENZ $23.92
- Average True Range (ATR)
- GRRR 6.46
- LENZ 1.42
- MACD
- GRRR -0.97
- LENZ 0.37
- Stochastic Oscillator
- GRRR 25.87
- LENZ 84.27
About GRRR Gorilla Technology Group Inc.
Gorilla Technology Group Inc is primarily engaged in providing information, software, and data processing services. It is a provider of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology (OT) security solutions and services. Its reportable segments are video IoT and security convergence and Other segments.
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing innovative therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.